Skip to content

Explore the markers of TCR and BCR in pregnant women with gestational diabetes mellitus, pregnant women with diabetes mellitus and their offspring based on immunoomics

Explore the markers of TCR and BCR in pregnant women with gestational diabetes mellitus, pregnant women with diabetes mellitus and their offspring based on immunoomics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096363
Enrollment
Unknown
Registered
2025-01-22
Start date
2025-02-10
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes mellitus/pregestational diabetes mellitus

Interventions

Pregnant women with gestational diabetes:None
Pregnant women with pregestational diabetes mellitus:None

Sponsors

Shanghai Sixth People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Gestational diabetes mellitus: 75g oral glucose tolerance test (OGTT) was performed for the first time at 24-28 weeks of pregnancy and after 28 weeks, and any of the following criteria were met: 5.1mmol/L=10.0mmol/L; or 8.5 mmol/L=7.0mmol/L; 75g oral glucose tolerance test, 2-hour blood glucose >=11.1 mmol/L; with typical symptoms of hyperglycemia or hyperglycemic crisis with arbitrary blood glucose >=11.1 mmol/L; glycosylated hemoglobin >=6.5%; (3) Healthy mothers: no abnormalities in the above blood glucose-related indicators.

Exclusion criteria

Exclusion criteria: 1. Combined with other autoimmune diseases; 2. Abnormal blood count, liver enzymes (ALT> 2 times normal) and coagulation function, moderate and severe renal impairment (serum creatinine > 2mg/dL or 177mmol/L); 3. Current or pre-existing HIV, hepatitis B, hepatitis C infection; 4. Laboratory or clinical evidence suggests the presence of serious infection; 5. Suffering from mental disorders or cognitive dysfunction; 6. Participated in a clinical trial within 6 weeks that may affect the disease or immune status; 7. Other factors that may affect the experiment.

Design outcomes

Primary

MeasureTime frame
TCR and BCR;

Secondary

MeasureTime frame
Glycosylated hemoglobin(HbA1c);Glycated albumin;Fasting blood glucose;Insulin;C-peptide;

Countries

China

Contacts

Public ContactHu Cheng

Shanghai Sixth People’s Hospital

qrb1218@sjtu.edu.cn+86 188 0134 2840

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026